Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.559
+0.039 (1.12%)
Mar 14, 2025, 11:29 AM EDT - Market open

Iovance Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,1672,2552,0811,0092,9956,806
Upgrade
Market Cap Growth
8.40%8.40%106.29%-66.33%-55.99%94.85%
Upgrade
Enterprise Value
8891,9371,7997292,4916,103
Upgrade
Last Close Price
3.527.408.136.3919.0946.40
Upgrade
PS Ratio
6.2213.751749.89---
Upgrade
PB Ratio
1.513.173.562.024.8210.37
Upgrade
P/TBV Ratio
5.275.275.862.024.8210.37
Upgrade
EV/Sales Ratio
5.4211.801512.80---
Upgrade
Debt / Equity Ratio
0.080.080.130.170.120.08
Upgrade
Asset Turnover
0.190.190.00---
Upgrade
Inventory Turnover
4.014.01----
Upgrade
Quick Ratio
3.213.212.545.165.6511.47
Upgrade
Current Ratio
3.743.742.795.245.6911.59
Upgrade
Return on Equity (ROE)
-57.48%-57.48%-81.91%-70.61%-53.55%-54.34%
Upgrade
Return on Assets (ROA)
-29.22%-29.22%-39.86%-34.59%-27.71%-29.41%
Upgrade
Return on Capital (ROIC)
-34.57%-34.57%-46.22%-39.01%-30.57%-32.14%
Upgrade
Earnings Yield
-32.25%-16.50%-21.34%-39.25%-11.43%-3.81%
Upgrade
FCF Yield
-31.54%-16.14%-18.46%-31.05%-8.86%-3.70%
Upgrade
Buyback Yield / Dilution
-23.28%-23.28%-47.64%-3.82%-10.92%-11.23%
Upgrade
Total Shareholder Return
-23.28%-23.28%-47.64%-3.82%-10.92%-11.23%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.